Abstract |
Selenium-containing quinone-based 1,2,3-triazoles were synthesized using click chemistry, the copper catalyzed azide- alkyne 1,3-dipolar cycloaddition, and evaluated against six types of cancer cell lines: HL-60 (human promyelocytic leukemia cells), HCT-116 (human colon carcinoma cells), PC3 (human prostate cells), SF295 (human glioblastoma cells), MDA-MB-435 ( melanoma cells) and OVCAR-8 (human ovarian carcinoma cells). Some compounds showed IC50 values < 0.3 μM. The cytotoxic potential of the quinones evaluated was also assayed using non- tumor cells, exemplified by peripheral blood mononuclear (PBMC), V79 and L929 cells. Mechanistic role for NAD(P)H:
Quinone Oxidoreductase 1 (NQO1) was also elucidated. These compounds could provide promising new lead derivatives for more potent anticancer drug development and delivery, and represent one of the most active classes of lapachones reported.
|
Authors | Eduardo H G da Cruz, Molly A Silvers, Guilherme A M Jardim, Jarbas M Resende, Bruno C Cavalcanti, Igor S Bomfim, Claudia Pessoa, Carlos A de Simone, Giancarlo V Botteselle, Antonio L Braga, Divya K Nair, Irishi N N Namboothiri, David A Boothman, Eufrânio N da Silva Júnior |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 122
Pg. 1-16
(Oct 21 2016)
ISSN: 1768-3254 [Electronic] France |
PMID | 27341379
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Benzoquinones
- Triazoles
- quinone
- Selenium
|
Topics |
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology, toxicity)
- Benzoquinones
(chemistry)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Chemistry Techniques, Synthetic
- Drug Design
- Humans
- Leukocytes, Mononuclear
(drug effects)
- Oxidation-Reduction
- Selenium
(chemistry)
- Structure-Activity Relationship
- Triazoles
(chemical synthesis, chemistry, pharmacology, toxicity)
|